Holcim (SIX:HOLN) shares soared 14% on Monday following the successful spin-off of its North American operations, now operating as a separate entity named Amrize. The move marks a significant structural shift for the Swiss construction materials giant as it refines its global business strategy.
The spin-off was carried out through a dividend-in-kind distribution, with Holcim shareholders receiving one Amrize share for each Holcim share held as of June 20. Amrize began trading on both the SIX Swiss Exchange and the New York Stock Exchange under the ticker “AMRZ.”
This strategic separation allows Holcim and Amrize to function as independent, publicly traded companies with focused leadership teams. Holcim CEO Miljan Gutovic described the development as “an exciting moment” for both firms, emphasizing the opportunity to pursue tailored growth strategies.
The spin-off supports Holcim’s “NextGen Growth 2030” roadmap, which targets expansion in Europe, Australia, North Africa, and accelerated growth in Latin America. With the North American business now operating independently, Holcim reported CHF 16.2 billion in net sales for 2024, excluding Amrize.
Amrize, which generated $11.7 billion in revenue in 2024, now leads operations across all 50 U.S. states and Canadian provinces, supported by a workforce of 19,000 employees. The newly listed company is expected to benefit from dedicated focus on the North American construction market, leveraging regional opportunities and streamlined operations.
The dual listing and spin-off position both Holcim and Amrize to better serve their markets and unlock shareholder value, aligning with long-term strategic goals and investor expectations.


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



